Regular intranasal insulin improves cognition in Alzheimer's disease, most likely due to its increased concentration in the brain, and the kinetics of intranasal adrenocorticotropic hormone (ACTH) indicate that it enters the brain. The gene discussed is POMC; the disease is early-onset autosomal dominant Alzheimer disease.